ArticleScientific reports2026
A retrospective analysis of chronic endometritis and antibiotic therapy in patients with endometriosis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic endometritis is linked to recurrent pregnancy loss and in vitro fertilization failure. The responsiveness to antibiotics suggests a bacterial cause, however endometriosis could also play a role. This study aimed to compare treatment responses to antibiotics of patients with and without endometriosis to find out if endometriosis-related immune changes affect treatment success. We included 92 infertile women with chronic endometritis in the study. Endometriosis was staged via laparoscopy according to the revised American Society for Reproductive Medicine, adenomyosis was defined using transvaginal ultrasound. All patients were reassessed via Pipelle® after oral doxycycline treatment. The main outcome parameter was the number of CD138 positive plasma cells per 20 high-power fields before and after doxycycline. In the univariable analysis, the presence of endometriosis (odds ratio, OR 2.893; p = 0.026) and adenomyosis (OR 10.277; p < 0.001) was associated with a higher risk of persistent chronic endometritis after doxycycline, whereas in the multivariable model, the presence of adenomyosis (OR, 18.393; p < 0.001) and the baseline number of plasma cells (OR 1.371; p = 0.026) remained statistically significant. Endometriosis and adenomyosis are risks for persistent chronic endometritis after doxycycline treatment. This could support the hypothesis that affected women could have heterogeneous endometrial immunological processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.